AIDS Research and Human Retroviruses, 1931-8405

Journal

More filtering options
  1. 2017
  2. Low Rates of Transmitted Drug Resistance Among Newly Identified HIV-1 Seroconverters in Rural Rakai, Uganda

    Reynolds, S. J., Ssempijja, V., Galiwango, R., Ndyanabo, A., Nakigozi, G., Lyagoba, F., Jamirah Nazziwa, Redd, A., Lamers, S. L., Gray, R., Wawer, M., Serwadda, D. & Quinn, T. C., 2017 May, In : AIDS Research and Human Retroviruses. 33, 5, p. 448-451 4 p.

    Research output: Contribution to journalArticle

  3. 2016
  4. Neutralizing Antibody Response and Antibody-Dependent Cellular Cytotoxicity in HIV-1-Infected Individuals from Guinea-Bissau and Denmark

    Borggren, M., Jensen, S. S., Heyndrickx, L., Palm, A. A., Gerstoft, J., Kronborg, G., Hønge, B. L., Jespersen, S., Da Silva, Z. J., Karlsson, I. & Fomsgaard, A., 2016, In : AIDS Research and Human Retroviruses. 32, 5, p. 434-442 9 p.

    Research output: Contribution to journalArticle

  5. 2015
  6. 2013
  7. Short communication: HIV type 1 transmitted drug resistance and evidence of transmission clusters among recently infected antiretroviral-naive individuals from Ugandan fishing communities of Lake Victoria

    Jamirah Nazziwa, Njai, H. F., Ndembi, N., Birungi, J., Lyagoba, F., Gershim, A., Nakiyingi-Miiro, J., Nielsen, L., Mpendo, J., Nanvubya, A., Debont, J., Grosskurth, H., Kamali, A., Seeley, J., Kaleebu, P. & Chivtum Study Team, 2013 May, In : AIDS Research and Human Retroviruses. 29, 5, p. 788-95 8 p.

    Research output: Contribution to journalArticle

  8. 2010
  9. Differential Effects of Efavirenz, Lopinavir/r, and Atazanavir/r on the Initial Viral Decay Rate in Treatment Naive HIV-1-Infected Patients

    Eden, A., Andersson, L-M., Andersson, O., Flamholc, L., Josephson, F., Nilsson, S., Ormaasen, V., Svedhem, V., Sall, C., Sonnerborg, A., Tunback, P. & Gisslen, M., 2010, In : AIDS Research and Human Retroviruses. 26, 5, p. 533-540

    Research output: Contribution to journalArticle

  10. Increased sensitivity to neutralizing antibodies of end-stage disease R5 HIV-1 is concomitant with reduced gp120 glycosylation and increased plus charge

    Eva Maria Fenyö, Borggren, M., Repits, J., Sterjovski, J., Uchtenhagen, H., Karlsson, A., Albert, J., Achour, A., Gorry, P. R. & Marianne Jansson, 2010, In : AIDS Research and Human Retroviruses. 26, 10, p. A55-A55

    Research output: Contribution to journalPublished meeting abstract

  11. 2009
  12. Mode of Coreceptor Use by R5 HIV Type 1 Correlates with Disease Stage: A Study of Paired Plasma and Cerebrospinal Fluid Isolates.

    Ulf Karlsson, Antonsson, L., Repits, J., Patrik Medstrand, Owman, C., Kidd-Ljunggren, K., Hagberg, L., Svennerholm, B., Marianne Jansson, Gisslén, M. & Bengt Ljungberg, 2009, In : AIDS Research and Human Retroviruses. 25, 12, p. 1297-1305

    Research output: Contribution to journalArticle

  13. 2008
  14. Global HIV Vaccine Research Cryorepository - GHRC

    von Briesen, H., Eva Maria Fenyö, Holmes, H., Karamov, E. V., Meyerhans, A., Morgado, M., Mullins, J. I., Osmanov, S., Preiser, W., Scarlatti, G., Sharma, O., Finzi, D., Sutthent, R. & Zimmermann, H., 2008, In : AIDS Research and Human Retroviruses. 24, p. 150-150

    Research output: Contribution to journalPublished meeting abstract

  15. Identification of a strongly activating human anti-CD40 antibody that suppresses HIV-1 infection

    Ellmark, P., Andersson, H., Abayneh, S., Eva Maria Fenyö & Carl Borrebaeck, 2008, In : AIDS Research and Human Retroviruses. 24, 3, p. 367-373

    Research output: Contribution to journalArticle

  16. Sensitivity of HIV-1 primary isolates to human anti-CD40 antibody-mediated suppression is related to co-receptor use

    Abayneh, S. A., Ellmark, P., Ulf Karlsson, Andersson, H., Carl Borrebaeck, Karlsson, I. & Eva Maria Fenyö, 2008, In : AIDS Research and Human Retroviruses. 24, 3, p. 447-452

    Research output: Contribution to journalArticle

  17. SIVmac239 is a Potent Immunogen for the Induction of Neutralizing Antibody Response

    Spetz, A., Sahin, G. O., Makitalo, B., Walther-Jallow, L., Spangberg, M., Thorstensson, R. & Eva Maria Fenyö, 2008, In : AIDS Research and Human Retroviruses. 24, p. 40-41

    Research output: Contribution to journalPublished meeting abstract

  18. Standardization of HIV Neutralization Assays for Use in Vaccine Research and Clinical Trials: Results from the NeutNet Working Group

    Scarlatti, G., Alcami, J., Bongertz, V., Dispinseri, S., Donners, H., Fenyö, E. M., Heath, A., Heyndrickx, L., Holmes, H., Jassoy, C., Lusso, P., Montefiori, D., Moog, C., Morris, L., Osmanov, S., Polonis, V. R., Sattentau, Q., Schuitemaker, H., Sutthent, R., Wrin, T. & 1 othersZolla-Pazner, S., 2008, In : AIDS Research and Human Retroviruses. 24, p. 44-44

    Research output: Contribution to journalPublished meeting abstract

  19. 2007
  20. Biological and genetic evolution of HIV type 1 in two siblings with different patterns of disease progression

    Ripamonti, C., Leitner, T., Laurén, A., Karlsson, I., Pastore, A., Cavarelli, M., Antonsson, L., Plebani, A., Eva Maria Fenyö & Scarlatti, G., 2007, In : AIDS Research and Human Retroviruses. 23, 12, p. 1531-1540

    Research output: Contribution to journalArticle

  21. 2005
  22. Coreceptor usage of primary HIV type 1 isolates obtained from different lymph node subsets

    Casper, C., Mild, M., Marianne Jansson, Karlsson, A., Holmberg, V., Bratt, G., van Paaschen, H., Biberfeld, P., Bjorndal, A., Albert, J., Popovic, M. & Eva Maria Fenyö, 2005, In : AIDS Research and Human Retroviruses. 21, 12, p. 1003-1010

    Research output: Contribution to journalArticle

  23. The X4 phenotype of HIV type 1 evolves from R5 in two children of mothers, carrying X4, and is not linked to transmission

    Clevestig, P., Maljkovic, I., Casper, C., Carlenor, E., Lindgren, S., Naver, L., Bohlin, A. B., Eva Maria Fenyö, Leitner, T. & Ehrnst, A., 2005, In : AIDS Research and Human Retroviruses. 21, 5, p. 371-378

    Research output: Contribution to journalArticle

  24. 2003
  25. Follow-up of antiretroviral treatment in liver transplant recipients with primary and chronic HIV type 1 infection

    Nowak, P., Schvarcz, R., Ericzon, BG., Flamholc, L. & Sonnerborg, A., 2003, In : AIDS Research and Human Retroviruses. 19, 1, p. 13-19

    Research output: Contribution to journalArticle

  26. 2002
  27. A new cell line-based neutralization assay for primary HIV type 1 isolates

    Shi, Y., Albert, J., Francis, G., Holmes, H. & Eva Maria Fenyö, 2002, In : AIDS Research and Human Retroviruses. 18, 13, p. 957-967

    Research output: Contribution to journalArticle

  28. Coreceptor change appears after immune deficiency is established in children infected with different HIV-1 subtypes

    Casper, C., Naver, L., Clevestig, P., Belfrage, E., Leitner, T., Albert, J., Lindgren, S., Ottenblad, C., Bohlin, AB., Eva Maria Fenyö & Ehrnst, A., 2002, In : AIDS Research and Human Retroviruses. 18, 5, p. 343-352

    Research output: Contribution to journalArticle

  29. Full-length HERV-H elements with env SU open reading frames in the human genome

    Jern, P., Lindeskog, M., Karlsson, D. & Blomberg, J., 2002, In : AIDS Research and Human Retroviruses. 18, 9, p. 671-676

    Research output: Contribution to journalArticle

  30. 2001
  31. Protection of neutralization epitopes in the V3 loop of oligomeric human immunodeficiency virus type I glycoprotein 120 by N-linked oligosaccharides in the V1 region

    Losman, B., Bolmstedt, A., Schonning, K., Björndal, Å., Westin, C., Eva Maria Fenyö & Olofsson, S., 2001, In : AIDS Research and Human Retroviruses. 17, 11, p. 1067-1076

    Research output: Contribution to journalArticle

  32. 1997